Designing improved active peptides for therapeutic approaches against infectious diseases
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10451/37677 |
Resumo: | © 2018 Elsevier Inc. All rights reserved. |
id |
RCAP_69c26404cf7672b9ecd01a9e642a0ab9 |
---|---|
oai_identifier_str |
oai:repositorio.ul.pt:10451/37677 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Designing improved active peptides for therapeutic approaches against infectious diseasesBiologically active peptidesAntimicrobial peptidesAntiviral peptidesCell-penetrating peptidesPeptide-based drugs© 2018 Elsevier Inc. All rights reserved.Infectious diseases are one of the main causes of human morbidity and mortality. In the last few decades, pathogenic microorganisms' resistance to conventional drugs has been increasing, and it is now pinpointed as a major worldwide health concern. The need to search for new therapeutic options, as well as improved treatment outcomes, has therefore increased significantly, with biologically active peptides representing a new alternative. A substantial research effort is being dedicated towards their development, especially due to improved biocompatibility and target selectivity. However, the inherent limitations of peptide drugs are restricting their application. In this review, we summarize the current status of peptide drug development, focusing on antiviral and antimicrobial peptide activities, highlighting the design improvements needed, and those already being used, to overcome the drawbacks of the therapeutic application of biologically active peptides.This work was supported by Fundação para a Ciência e a Tecnologia – Ministério da Ciência, Tecnologia e Ensino Superior (FCT-MCTES, Portugal) project PTDC/BBB-BQB/3494/2014, by Marie SkłodowskaCurie Research and Innovation Staff Exchange (MSCA-RISE, European Union) project INPACT (call H2020-MSCA-RISE-2014, grant agreement 644167), by the Brazilian funding agencies Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo a Pesquisa do Distrito Federal (FAPDF) and by Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT). BG, MA and MF acknowledge FCT-MCTES fellowships SPRH/BD/ 52431/2013, SPRH/BD/95624/2013 and SPRH/BD/100517/2014, respectively.ElsevierRepositório da Universidade de LisboaGomes, BárbaraAugusto, Marcelo T.Felício, Mário RomãoHollmann, AxelFranco, Octávio L.Abreu, Sónia GonçalvesSantos, Nuno C.2019-03-25T12:16:45Z20182018-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfhttp://hdl.handle.net/10451/37677engBiotechnology Advances 36 (2018) 415–4290734-975010.1016/j.biotechadv.2018.01.004info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:34:56Zoai:repositorio.ul.pt:10451/37677Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:51:40.825755Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Designing improved active peptides for therapeutic approaches against infectious diseases |
title |
Designing improved active peptides for therapeutic approaches against infectious diseases |
spellingShingle |
Designing improved active peptides for therapeutic approaches against infectious diseases Gomes, Bárbara Biologically active peptides Antimicrobial peptides Antiviral peptides Cell-penetrating peptides Peptide-based drugs |
title_short |
Designing improved active peptides for therapeutic approaches against infectious diseases |
title_full |
Designing improved active peptides for therapeutic approaches against infectious diseases |
title_fullStr |
Designing improved active peptides for therapeutic approaches against infectious diseases |
title_full_unstemmed |
Designing improved active peptides for therapeutic approaches against infectious diseases |
title_sort |
Designing improved active peptides for therapeutic approaches against infectious diseases |
author |
Gomes, Bárbara |
author_facet |
Gomes, Bárbara Augusto, Marcelo T. Felício, Mário Romão Hollmann, Axel Franco, Octávio L. Abreu, Sónia Gonçalves Santos, Nuno C. |
author_role |
author |
author2 |
Augusto, Marcelo T. Felício, Mário Romão Hollmann, Axel Franco, Octávio L. Abreu, Sónia Gonçalves Santos, Nuno C. |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório da Universidade de Lisboa |
dc.contributor.author.fl_str_mv |
Gomes, Bárbara Augusto, Marcelo T. Felício, Mário Romão Hollmann, Axel Franco, Octávio L. Abreu, Sónia Gonçalves Santos, Nuno C. |
dc.subject.por.fl_str_mv |
Biologically active peptides Antimicrobial peptides Antiviral peptides Cell-penetrating peptides Peptide-based drugs |
topic |
Biologically active peptides Antimicrobial peptides Antiviral peptides Cell-penetrating peptides Peptide-based drugs |
description |
© 2018 Elsevier Inc. All rights reserved. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018 2018-01-01T00:00:00Z 2019-03-25T12:16:45Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10451/37677 |
url |
http://hdl.handle.net/10451/37677 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Biotechnology Advances 36 (2018) 415–429 0734-9750 10.1016/j.biotechadv.2018.01.004 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134452890206208 |